1 Study Coverage 1.1 Type-1 Diabetes Treatment Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Introduction 1.2 Global Type-1 Diabetes Treatment Outlook 2017 VS 2022 VS 2028 1.2.1 Global Type-1 Diabetes Treatment Market Size for the Year 2017-2028 1.2.2 Global Type-1 Diabetes Treatment Market Size for the Year 2017-2028 1.3 Type-1 Diabetes Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Type-1 Diabetes Treatment in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Type-1 Diabetes Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Type-1 Diabetes Treatment Market Dynamics 1.4.1 Type-1 Diabetes Treatment Industry Trends 1.4.2 Type-1 Diabetes Treatment Market Drivers 1.4.3 Type-1 Diabetes Treatment Market Challenges 1.4.4 Type-1 Diabetes Treatment Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Type-1 Diabetes Treatment by Type 2.1 Type-1 Diabetes Treatment Market Segment by Type 2.1.1 Rapid-Acting Insulin 2.1.2 Short-Acting Insulin 2.1.3 Others 2.2 Global Type-1 Diabetes Treatment Market Size by Type (2017, 2022 & 2028) 2.3 Global Type-1 Diabetes Treatment Market Size by Type (2017-2028) 2.4 United States Type-1 Diabetes Treatment Market Size by Type (2017, 2022 & 2028) 2.5 United States Type-1 Diabetes Treatment Market Size by Type (2017-2028) 3 Type-1 Diabetes Treatment by Application 3.1 Type-1 Diabetes Treatment Market Segment by Application 3.1.1 Hospitals & Clinics 3.1.2 Academic & Research Institutes 3.2 Global Type-1 Diabetes Treatment Market Size by Application (2017, 2022 & 2028) 3.3 Global Type-1 Diabetes Treatment Market Size by Application (2017-2028) 3.4 United States Type-1 Diabetes Treatment Market Size by Application (2017, 2022 & 2028) 3.5 United States Type-1 Diabetes Treatment Market Size by Application (2017-2028) 4 Global Type-1 Diabetes Treatment Competitor Landscape by Company 4.1 Global Type-1 Diabetes Treatment Market Size by Company 4.1.1 Top Global Type-1 Diabetes Treatment Companies Ranked by Revenue (2021) 4.1.2 Global Type-1 Diabetes Treatment Revenue by Player (2017-2022) 4.2 Global Type-1 Diabetes Treatment Concentration Ratio (CR) 4.2.1 Type-1 Diabetes Treatment Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Type-1 Diabetes Treatment in 2021 4.2.3 Global Type-1 Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Type-1 Diabetes Treatment Headquarters, Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Type 4.3.1 Global Type-1 Diabetes Treatment Headquarters and Area Served 4.3.2 Global Type-1 Diabetes Treatment Companies Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Type-1 Diabetes Treatment Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Type-1 Diabetes Treatment Market Size by Company 4.5.1 Top Type-1 Diabetes Treatment Players in United States, Ranked by Revenue (2021) 4.5.2 United States Type-1 Diabetes Treatment Revenue by Players (2020, 2021 & 2022) 5 Global Type-1 Diabetes Treatment Market Size by Region 5.1 Global Type-1 Diabetes Treatment Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Type-1 Diabetes Treatment Market Size by Region (2017-2028) 5.2.1 Global Type-1 Diabetes Treatment Market Size by Region: 2017-2022 5.2.2 Global Type-1 Diabetes Treatment Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Type-1 Diabetes Treatment Market Size YoY Growth 2017-2028 6.1.2 North America Type-1 Diabetes Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Type-1 Diabetes Treatment Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Type-1 Diabetes Treatment Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Type-1 Diabetes Treatment Market Size YoY Growth 2017-2028 6.3.2 Europe Type-1 Diabetes Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Type-1 Diabetes Treatment Market Size YoY Growth 2017-2028 6.4.2 Latin America Type-1 Diabetes Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Type-1 Diabetes Treatment Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Type-1 Diabetes Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Astellas Pharma 7.1.1 Astellas Pharma Company Details 7.1.2 Astellas Pharma Business Overview 7.1.3 Astellas Pharma Type-1 Diabetes Treatment Introduction 7.1.4 Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2017-2022) 7.1.5 Astellas Pharma Recent Development 7.2 Merck 7.2.1 Merck Company Details 7.2.2 Merck Business Overview 7.2.3 Merck Type-1 Diabetes Treatment Introduction 7.2.4 Merck Revenue in Type-1 Diabetes Treatment Business (2017-2022) 7.2.5 Merck Recent Development 7.3 Eli Lilly 7.3.1 Eli Lilly Company Details 7.3.2 Eli Lilly Business Overview 7.3.3 Eli Lilly Type-1 Diabetes Treatment Introduction 7.3.4 Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2017-2022) 7.3.5 Eli Lilly Recent Development 7.4 Novo Nordisk 7.4.1 Novo Nordisk Company Details 7.4.2 Novo Nordisk Business Overview 7.4.3 Novo Nordisk Type-1 Diabetes Treatment Introduction 7.4.4 Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2017-2022) 7.4.5 Novo Nordisk Recent Development 7.5 Sanofi 7.5.1 Sanofi Company Details 7.5.2 Sanofi Business Overview 7.5.3 Sanofi Type-1 Diabetes Treatment Introduction 7.5.4 Sanofi Revenue in Type-1 Diabetes Treatment Business (2017-2022) 7.5.5 Sanofi Recent Development 7.6 AstraZeneca 7.6.1 AstraZeneca Company Details 7.6.2 AstraZeneca Business Overview 7.6.3 AstraZeneca Type-1 Diabetes Treatment Introduction 7.6.4 AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2017-2022) 7.6.5 AstraZeneca Recent Development 7.7 Boehringer Ingelheim GmbH 7.7.1 Boehringer Ingelheim GmbH Company Details 7.7.2 Boehringer Ingelheim GmbH Business Overview 7.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Introduction 7.7.4 Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2017-2022) 7.7.5 Boehringer Ingelheim GmbH Recent Development 7.8 Novartis 7.8.1 Novartis Company Details 7.8.2 Novartis Business Overview 7.8.3 Novartis Type-1 Diabetes Treatment Introduction 7.8.4 Novartis Revenue in Type-1 Diabetes Treatment Business (2017-2022) 7.8.5 Novartis Recent Development 7.9 Pfizer Inc. 7.9.1 Pfizer Inc. Company Details 7.9.2 Pfizer Inc. Business Overview 7.9.3 Pfizer Inc. Type-1 Diabetes Treatment Introduction 7.9.4 Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2017-2022) 7.9.5 Pfizer Inc. Recent Development 7.10 Abbott Laboratories 7.10.1 Abbott Laboratories Company Details 7.10.2 Abbott Laboratories Business Overview 7.10.3 Abbott Laboratories Type-1 Diabetes Treatment Introduction 7.10.4 Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2017-2022) 7.10.5 Abbott Laboratories Recent Development 7.11 Mannkind Corporation 7.11.1 Mannkind Corporation Company Details 7.11.2 Mannkind Corporation Business Overview 7.11.3 Mannkind Corporation Type-1 Diabetes Treatment Introduction 7.11.4 Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2017-2022) 7.11.5 Mannkind Corporation Recent Development 7.12 Braun Melsungen AG 7.12.1 Braun Melsungen AG Company Details 7.12.2 Braun Melsungen AG Business Overview 7.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Introduction 7.12.4 Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2017-2022) 7.12.5 Braun Melsungen AG Recent Development 7.13 Macrogenics, Inc. 7.13.1 Macrogenics, Inc. Company Details 7.13.2 Macrogenics, Inc. Business Overview 7.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Introduction 7.13.4 Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2017-2022) 7.13.5 Macrogenics, Inc. Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Type-1 Diabetes Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Type-1 Diabetes Treatment Market Trends Table 3. Type-1 Diabetes Treatment Market Drivers Table 4. Type-1 Diabetes Treatment Market Challenges Table 5. Type-1 Diabetes Treatment Market Restraints Table 6. Global Type-1 Diabetes Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Type-1 Diabetes Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Type-1 Diabetes Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Type-1 Diabetes Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Type-1 Diabetes Treatment Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Type-1 Diabetes Treatment Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Type-1 Diabetes Treatment Revenue Share by Player, 2017-2022 Table 13. Global Type-1 Diabetes Treatment Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Type-1 Diabetes Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type-1 Diabetes Treatment as of 2021) Table 15. Top Players of Type-1 Diabetes Treatment in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Type-1 Diabetes Treatment Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Type-1 Diabetes Treatment Players in United States Market, Ranking by Revenue (2021) Table 20. United States Type-1 Diabetes Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Type-1 Diabetes Treatment Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Type-1 Diabetes Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Type-1 Diabetes Treatment Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Type-1 Diabetes Treatment Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Type-1 Diabetes Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Type-1 Diabetes Treatment Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Type-1 Diabetes Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Type-1 Diabetes Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Type-1 Diabetes Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Astellas Pharma Company Details Table 31. Astellas Pharma Business Overview Table 32. Astellas Pharma Type-1 Diabetes Treatment Product Table 33. Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Table 34. Astellas Pharma Recent Development Table 35. Merck Company Details Table 36. Merck Business Overview Table 37. Merck Type-1 Diabetes Treatment Product Table 38. Merck Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Table 39. Merck Recent Development Table 40. Eli Lilly Company Details Table 41. Eli Lilly Business Overview Table 42. Eli Lilly Type-1 Diabetes Treatment Product Table 43. Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Table 44. Eli Lilly Recent Development Table 45. Novo Nordisk Company Details Table 46. Novo Nordisk Business Overview Table 47. Novo Nordisk Type-1 Diabetes Treatment Product Table 48. Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Table 49. Novo Nordisk Recent Development Table 50. Sanofi Company Details Table 51. Sanofi Business Overview Table 52. Sanofi Type-1 Diabetes Treatment Product Table 53. Sanofi Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Table 54. Sanofi Recent Development Table 55. AstraZeneca Company Details Table 56. AstraZeneca Business Overview Table 57. AstraZeneca Type-1 Diabetes Treatment Product Table 58. AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Table 59. AstraZeneca Recent Development Table 60. Boehringer Ingelheim GmbH Company Details Table 61. Boehringer Ingelheim GmbH Business Overview Table 62. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product Table 63. Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Table 64. Boehringer Ingelheim GmbH Recent Development Table 65. Novartis Company Details Table 66. Novartis Business Overview Table 67. Novartis Type-1 Diabetes Treatment Product Table 68. Novartis Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Table 69. Novartis Recent Development Table 70. Pfizer Inc. Company Details Table 71. Pfizer Inc. Business Overview Table 72. Pfizer Inc. Type-1 Diabetes Treatment Product Table 73. Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Table 74. Pfizer Inc. Recent Development Table 75. Abbott Laboratories Company Details Table 76. Abbott Laboratories Business Overview Table 77. Abbott Laboratories Type-1 Diabetes Treatment Product Table 78. Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Table 79. Abbott Laboratories Recent Development Table 80. Mannkind Corporation Company Details Table 81. Mannkind Corporation Business Overview Table 82. Mannkind Corporation Type-1 Diabetes Treatment Product Table 83. Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Table 84. Mannkind Corporation Recent Development Table 85. Braun Melsungen AG Company Details Table 86. Braun Melsungen AG Business Overview Table 87. Braun Melsungen AG Type-1 Diabetes Treatment Product Table 88. Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Table 89. Braun Melsungen AG Recent Development Table 90. Macrogenics, Inc. Company Details Table 91. Macrogenics, Inc. Business Overview Table 92. Macrogenics, Inc. Type-1 Diabetes Treatment Product Table 93. Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Table 94. Macrogenics, Inc. Recent Development Table 95. Research Programs/Design for This Report Table 96. Key Data Information from Secondary Sources Table 97. Key Data Information from Primary Sources List of Figures Figure 1. Type-1 Diabetes Treatment Product Picture Figure 2. Global Type-1 Diabetes Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Type-1 Diabetes Treatment Market Size 2017-2028 (US$ Million) Figure 4. United States Type-1 Diabetes Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Type-1 Diabetes Treatment Market Size 2017-2028 (US$ Million) Figure 6. United States Type-1 Diabetes Treatment Market Share in Global 2017-2028 Figure 7. Type-1 Diabetes Treatment Report Years Considered Figure 8. Product Picture of Rapid-Acting Insulin Figure 9. Product Picture of Short-Acting Insulin Figure 10. Product Picture of Others Figure 11. Global Type-1 Diabetes Treatment Market Share by Type in 2022 & 2028 Figure 12. Global Type-1 Diabetes Treatment Market Size by Type (2017-2028) & (US$ Million) Figure 13. Global Type-1 Diabetes Treatment Market Share by Type (2017-2028) Figure 14. United States Type-1 Diabetes Treatment Market Share by Type in 2022 & 2028 Figure 15. United States Type-1 Diabetes Treatment Market Size by Type (2017-2028) & (US$ Million) Figure 16. United States Type-1 Diabetes Treatment Market Share by Type (2017-2028) Figure 17. Product Picture of Hospitals & Clinics Figure 18. Product Picture of Academic & Research Institutes Figure 19. Global Type-1 Diabetes Treatment Market Share by Application in 2022 & 2028 Figure 20. Global Type-1 Diabetes Treatment Market Size by Application (2017-2028) & (US$ Million) Figure 21. Global Type-1 Diabetes Treatment Market Share by Application (2017-2028) Figure 22. United States Type-1 Diabetes Treatment Market Share by Application in 2022 & 2028 Figure 23. United States Type-1 Diabetes Treatment Market Size by Application (2017-2028) & (US$ Million) Figure 24. United States Type-1 Diabetes Treatment Market Share by Application (2017-2028) Figure 25. North America Type-1 Diabetes Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 26. U.S. Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 27. Canada Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Europe Type-1 Diabetes Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. Germany Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. France Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. U.K. Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. Italy Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Russia Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Type-1 Diabetes Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 35. China Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Japan Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. South Korea Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. India Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Australia Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Taiwan Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Indonesia Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Thailand Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Malaysia Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Philippines Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Latin America Type-1 Diabetes Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 46. Mexico Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Brazil Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Argentina Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Type-1 Diabetes Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 50. Turkey Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Saudi Arabia Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. U.A.E Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Astellas Pharma Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022) Figure 54. Merck Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022) Figure 55. Eli Lilly Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022) Figure 56. Novo Nordisk Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022) Figure 57. Sanofi Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022) Figure 58. AstraZeneca Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022) Figure 59. Boehringer Ingelheim GmbH Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022) Figure 60. Novartis Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022) Figure 61. Pfizer Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022) Figure 62. Abbott Laboratories Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022) Figure 63. Mannkind Corporation Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022) Figure 64. Braun Melsungen AG Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022) Figure 65. Macrogenics, Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Astellas Pharma Merck Eli Lilly Novo Nordisk Sanofi AstraZeneca Boehringer Ingelheim GmbH Novartis Pfizer Inc. Abbott Laboratories Mannkind Corporation Braun Melsungen AG Macrogenics, Inc.